Skip to main content

ResMed Inc.

corporate_fare Company Profile

ResMed Inc.

RMD·NYSE·Industrial Applications And Services·CIK 0000943819

ResMed Inc. is a global leader in digital health and cloud-connected medical devices. The company designs innovative technology, including artificial intelligence (AI) powered digital health solutions, cloud-connected devices, and intelligent software, to make home healthcare more personalized, accessible, and effective. Its products aim to improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems. Formed in 1989, ResMed commercialized a continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea (OSA), which was the first successful non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a mask, to prevent upper airway collapse during sleep. The company has since expanded its business to include innovative products and solutions for a broad range of sleep and related breathing health disorders. These technologies are applied in medical and consumer products, life support and ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, and dental devices. ResMed is also a leading provider of cloud-based health applications, software, and devices for connected care. These solutions enable clinicians to manage more patients efficiently and effectively, and encourage patients' long-term adherence to and satisfaction with their therapy. In June 2026, ResMed acquired Noctrix Health, LLC, a company with an FDA De Novo classified medical device that treats restless legs syndrome. This acquisition expands ResMed's clinical sleep health portfolio into an adjacent area of unmet need, with Noctrix operating as a wholly owned subsidiary.

ResMed Inc. (NYSE:RMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 18 items for RMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 7/10. Across its 18 most recent items scored 7 or higher, the top rating is 8/10, with 6 rated 8 or above. Recent SEC coverage for RMD spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • ResMed Q1 EPS $2.92 as MatrixCare Sale Adds $62M Gain
  • ResMed Posts 1Q EPS of $2.92
  • ResMed Launches $450M Accelerated Buyback Funded by MatrixCare Sale
  • ResMed Launches $450M Accelerated Share Repurchase with Citibank
  • ResMed Swaps Auditors from KPMG to PwC and Names Carol Burt Lead Director

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$5.65B
Net Income
$1.52B
Diluted EPS
$10.43
Op. Cash Flow
$1.81B
Free Cash Flow
$1.65B
Gross Profit
$3.45B
Operating Income
$1.89B
Cash & Equivalents
$1.47B
Total Debt
$659.37M
Debt / Equity
0.10×
Net Margin
26.9%
Shares Outstanding
144.24M sh
Source: 10-K · filed 2026-08-13 · accession 0000943819-26-000047

Short Interest & Short Volume

7.05 days to cover

FINRA reported short interest of 10,471,435 shares in RMD as of the October 30, 2026 settlement, a 12.1% decrease from the prior period — about 7.0 days to cover at its recent average daily volume. On November 20, 2026, 89.2% of RMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)10,471,435 shares as of October 30, 2026
Change vs prior period▼ 12.1%
Days to cover7.05 at avg daily volume of 1,485,271
Daily short volume (FINRA facilities)89.2% of 532,698 shares on November 20, 2026
5-day average short volume75.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with R →
$235.63
52-week range · as of 2026-10-29 $180.26 – $277.67
Market cap
$33.14B
Volume
1.4M (1.0× avg)
3-mo avg 1.4M
Live data · 2026-11-21 13:55 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed RMD - Latest Insights

RMD
Oct 29, 2026, 6:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $253.00
Real-time Price: $235.63 info
Change: -$17.37 (-7%) info
Market Cap: $33.143B info
RMD
Oct 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $252.83
Real-time Price: $235.63 info
Change: -$17.20 (-7%) info
Market Cap: $33.143B info
RMD
Sep 01, 2026, 4:39 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $231.75
Real-time Price: $235.63 info
Change: +$3.88 (+2%) info
Market Cap: $33.143B info
RMD
Sep 01, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $231.36
Real-time Price: $235.63 info
Change: +$4.27 (+2%) info
Market Cap: $33.143B info
RMD
Aug 17, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $220.37
Real-time Price: $235.63 info
Change: +$15.26 (+7%) info
Market Cap: $33.143B info
RMD
Aug 13, 2026, 5:17 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $226.74
Real-time Price: $235.63 info
Change: +$8.89 (+4%) info
Market Cap: $33.143B info
RMD
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $211.00
Real-time Price: $235.63 info
Change: +$24.63 (+12%) info
Market Cap: $33.143B info
RMD
Aug 07, 2026, 12:39 AM EDT
Source: Market Index
Importance Score:
8
Price at Filing: $212.50
Real-time Price: $235.63 info
Change: +$23.13 (+11%) info
Market Cap: $33.143B info
RMD
Aug 06, 2026, 10:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $212.50
Real-time Price: $235.63 info
Change: +$23.13 (+11%) info
Market Cap: $33.143B info
RMD
Aug 06, 2026, 4:54 PM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $212.17
Real-time Price: $235.63 info
Change: +$23.46 (+11%) info
Market Cap: $33.143B info
RMD
Jul 13, 2026, 4:35 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $198.50
Real-time Price: $235.63 info
Change: +$37.13 (+19%) info
Market Cap: $33.143B info
RMD
Jul 07, 2026, 6:12 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $218.92
Real-time Price: $235.63 info
Change: +$16.71 (+8%) info
Market Cap: $33.143B info
RMD
Jul 07, 2026, 5:24 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $218.92
Real-time Price: $235.63 info
Change: +$16.71 (+8%) info
Market Cap: $33.143B info
RMD
May 19, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $201.88
Real-time Price: $235.63 info
Change: +$33.75 (+17%) info
Market Cap: $33.143B info
RMD
Apr 30, 2026, 4:17 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $208.00
Real-time Price: $235.63 info
Change: +$27.63 (+13%) info
Market Cap: $33.143B info
RMD
Feb 27, 2026, 3:15 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $255.22
Real-time Price: $235.63 info
Change: -$19.59 (-8%) info
Market Cap: $33.143B info
RMD
Jan 29, 2026, 7:37 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $266.20
Real-time Price: $235.63 info
Change: -$30.57 (-11%) info
Market Cap: $33.143B info
RMD
Jan 29, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $257.61
Real-time Price: $235.63 info
Change: -$21.98 (-9%) info
Market Cap: $33.143B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets